Abstract:Estradiol (E 2 ) has been proven to be effective in treating perimenopausal depression (PD); however, the downstream signaling pathways have not been fully elucidated. Transient receptor potential channels 6 (TRPC6) plays a vital role in promoting neuronal development and the formation of excitatory synapses. At present, we found that the serum levels of E 2 and brain-derived neurotrophic factor (BDNF) declined significantly in the women with PD compared to perimenopausal women, which was accompanied by a clear reduction in TRPC6 levels. To further reveal the effects of TRPC6 on neuronal survival and excitability, the PD-like rat model was established by the total removal of left ovary and 80% removal of right ovary followed by 21 days of the chronic unpredictable mild stress. Intragastric administration of E 2 (2 mg/kg), intraperitoneal injection of BDNF/TrB signaling pathway inhibitor (K252a, 100 μg/kg) and TRPC6 agonist (OAG, 0.6 mg/kg), and intracerebroventricular infusion of anti-BDNF antibody for blocking BDNF (0.5 μg/24 μl/rat) daily for 21 days were conducted. The levels of BDNF and TRPC6 in rat serum were lower in PD rats compared to the control rats; the depression-like behavior was induced, the neuronal death rate in the hippocampus increased, and the thickness of postsynaptic density (PSD) and the number of asymmetric synapses decreased significantly in the PD group. E 2 treatment greatly upregulated the serum levels of BDNF and TRPC6, the neuronal excitability indicated by an elevation in the PSD thickness and the numbers of asymmetric synapses, and these actions were reversed by K252a; co-administration of TRPC6 agonist and K252a improved neuronal degeneration and increased the neuronal excitability induced in the E 2 -treated PD rats. K252a or anti-BDNF antibody inhibited the increased neuronal BDNF and TRPC6 expression in E 2 -treated PD rats; co-treatment of TRPC6 agonist and anti-BDNF antibody reduced neuronal death and increased the BDNF and TRPC6 expression in the hippocampal CA1 neurons in the E 2 -treated PD rats. These results suggest that the neuroprotective role of E 2 in PD is closely related to enhance the activity of BDNF/TRPC6 pathway and is helpful to provide new prevention and strategies.

Estradiol Reduced 5-HT Reuptake by Downregulating the Gene Expression of Plasma Membrane Monoamine Transporter (PMAT, Slc29a4) Through Estrogen Receptor Β and the MAPK/ERK Signaling Pathway.

Aromatase Changes in Depression: A Postmortem and Animal Experimental Study.

Estrogen Receptor Α Drives Pro-Resilient Transcription in Mouse Models of Depression.

17β-Estradiol (E2) Alleviates Depressive-Like Behaviors By Inhibiting Gp130/JAK1/STAT3 Signaling Pathway Through Estrogen Receptor-β

Luteolin Shows Antidepressant-Like Effect by Inhibiting and Downregulating Plasma Membrane Monoamine Transporter (PMAT, Slc29a4)

Comparison of the Effects of Estradiol and Progesterone on Serotonergic Function

Estradiol attenuates chronic restraint stress-induced dendrite and dendritic spine loss and cofilin1 activation in ovariectomized mice

Effects of estrogen on behavior and monoamine neurotransmitters of brain tissue in depressed mice

[Influence of Estradiol on Tryptophan Hydroxylase and 5-Hydroxytryptamine Content in Raphe Nuclei of Rats under Forced Swimming Stress].

Effect of Pueraria Mirifica Subchronic Treatments on Ameliorating Depression by Increasing Tryptophan Hydroxylase Immunoreactive Neurons Via Estrogen Receptors in Ovariectomized Mice

Quercetin exerts antidepressant and cardioprotective effects in estrogen receptor α-deficient female mice via BDNF-AKT/ERK1/2 signaling

Role of estrogen in treatment of female depression

Brain estrogen alters the effects of the antidepressant sertraline in middle-aged female and male mice

Gut-microbiome-expressed 3β-hydroxysteroid dehydrogenase degrades estradiol and is linked to depression in premenopausal females

A direct estrogenic involvement in the expression of human hypocretin

Study of Sex Differences in Duloxetine Efficacy for Depression in Transgenic Mouse Models

Neuroprotective Effects of Estrogen Through BDNF-Transient Receptor Potential Channels 6 Signaling Pathway in the Hippocampus in a Rat Model of Perimenopausal Depression

Estrogen receptors mediate the antidepressant effects of aerobic exercise: A possible new mechanism

Estradiol or fluoxetine alters depressive behavior and tryptophan hydroxylase in rat raphe.

Vortioxetine attenuates the effects of early-life stress on depression-like behaviors and monoamine transporters in female mice